Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4257)
All Articles published online
|
Jan 7, 2008 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, Yokoyama N, Watanabe G, Nishikura K, Wakai T, Shirai Y, Hatakeyama K, Yamamoto M. Genetic changes of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/70.htm |
| Number | Citing Articles |
| 1 |
Nivedita Sharma, Anjali Tomar, P. K. Tiwari. Gallbladder Cancer. 2023; : 201 doi: 10.1007/978-981-19-6442-8_12
|
| 2 |
You-Na Sung, Sung Joo Kim, Sun-Young Jun, Changhoon Yoo, Kyu-Pyo Kim, Jae Hoon Lee, Dae Wook Hwang, Shin Hwang, Sang Soo Lee, Seung-Mo Hong. Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.658564
|
| 3 |
Pomilla Singh, Shyam Lata Jain, Puja Sakhuja, Anil Agarwal. Expression of VEGF-A, HER2/neu, and KRAS in gall bladder carcinoma and their correlation with clinico-pathological parameters. Indian Journal of Pathology and Microbiology 2021; 64(4): 687 doi: 10.4103/IJPM.IJPM_248_20
|
| 4 |
Jiwen Wang, Han Liu, Xiaokun Shen, Yueqi Wang, Dexiang Zhang, Sheng Shen, Tao Suo, Hongtao Pan, Yue Ming, Kan Ding, Houbao Liu. Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis. Oncology Letters 2017; 13(5): 3508 doi: 10.3892/ol.2017.5893
|
| 5 |
Lei Zhang, Zhimin Geng, Xiankui Meng, Fandi Meng, Lin Wang. Screening for key lncRNAs in the progression of gallbladder cancer using bioinformatics analyses. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8655
|
| 6 |
Benjamin Goeppert, Stephanie Roessler, Marcus Renner, Moritz Loeffler, Stephan Singer, Melina Rausch, Thomas Albrecht, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil, Elena Czink, Bruno Köhler, Christoph Springfeld, Christian Rupp, Karl Heinz Weiss, Peter Schirmacher, Magnus von Knebel Doeberitz, Matthias Kloor. Low frequency of mismatch repair deficiency in gallbladder cancer. Diagnostic Pathology 2019; 14(1) doi: 10.1186/s13000-019-0813-5
|
| 7 |
Xiao‐Cai Wu, Shou‐hua Wang, Hong‐hui Ou, Bing Zhu, Yong Zhu, Qi Zhang, Yang Yang, Hua Li. The NmrA‐like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial–mesenchymal transition. Chemical Biology & Drug Design 2017; 90(3): 456 doi: 10.1111/cbdd.12967
|
| 8 |
Peter Zauber, Stephen Marotta, Marlene Sabbath-Solitare. Adenocarcinomas of the gallbladder from United States patients demonstrate less frequent molecular change for several genetic markers than other intra-abdominal cancers. Open Journal of Gastroenterology 2013; 3(08): 337 doi: 10.4236/ojgas.2013.38059
|
| 9 |
Masayuki Nagahashi, Yasunobu Matsuda, Kazuki Moro, Junko Tsuchida, Daiki Soma, Yuki Hirose, Takashi Kobayashi, Shin-ichi Kosugi, Kazuaki Takabe, Masaaki Komatsu, Toshifumi Wakai. DNA damage response and sphingolipid signaling in liver diseases. Surgery Today 2016; 46(9): 995 doi: 10.1007/s00595-015-1270-8
|
| 10 |
Hendrien Kuipers, Tessa J. J. de Bitter, Marieke T. de Boer, Rachel S. van der Post, Maarten W. Nijkamp, Philip R. de Reuver, Rudolf S. N. Fehrmann, Frederik J. H. Hoogwater. Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications. Cancers 2021; 13(21): 5257 doi: 10.3390/cancers13215257
|
| 11 |
Munita Meenu Bal, Mukta Ramadwar, Kedar Deodhar, Shailesh Shrikhande. Pathology of Gallbladder Carcinoma: Current Understanding and New Perspectives. Pathology & Oncology Research 2015; 21(3): 509 doi: 10.1007/s12253-014-9886-3
|
| 12 |
Davendra P.S. Sohal, Shiva Shrotriya, Mohamed Abazeed, Michael Cruise, Alok Khorana. Molecular characteristics of biliary tract cancer. Critical Reviews in Oncology/Hematology 2016; 107: 111 doi: 10.1016/j.critrevonc.2016.08.013
|
| 13 |
Yingyu Ma, Liang Wu, Cuiping Liu, Liqian Xu, Dongmei Li, Ji-Cheng Li. The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. Journal of Cancer Research and Clinical Oncology 2009; 135(3): 431 doi: 10.1007/s00432-008-0471-6
|
| 14 |
Ming-zhe Ma, Chun-xiao Li, Yan Zhang, Ming-zhe Weng, Ming-di Zhang, Yi-yu Qin, Wei Gong, Zhi-wei Quan. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-156
|
| 15 |
Takao Asai, Ernesto Loza, Guido Villa-Gomez Roig, Yoichi Ajioka, Yasuo Tsuchiya, Masaharu Yamamoto, Kazutoshi Nakamura. High Frequency of TP53 but not K-ras Gene Mutations in Bolivian Patients with Gallbladder Cancer. Asian Pacific Journal of Cancer Prevention 2014; 15(13): 5449 doi: 10.7314/APJCP.2014.15.13.5449
|
| 16 |
Xin‐Min Xu, Jian‐Chang Qian, Zhe Cai, Tao Tang, Peng Wang, Ke‐Hua Zhang, Zhou‐Lu Deng, Jian‐Ping Cai. DNA alterations of microsatellite DNA, p53, APC and K‐ras in Chinese colorectal cancer patients. European Journal of Clinical Investigation 2012; 42(7): 751 doi: 10.1111/j.1365-2362.2011.02641.x
|
| 17 |
Stefano Cereda, Carmen Belli, Alessia Rognone, Elena Mazza, Michele Reni. Second-line therapy in advanced biliary tract cancer: What should be the standard?. Critical Reviews in Oncology/Hematology 2013; 88(2): 368 doi: 10.1016/j.critrevonc.2013.05.010
|
| 18 |
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu. Overview of current targeted therapy in gallbladder cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00324-2
|
| 19 |
Niraj Kumari, Vinay K. Kapoor, Narendra Krishnani, Kamlesh Kumar, Dinesh Kumar Baitha, Anu Behari. Microsatellite instability and loss of fragile histidine triad in gallbladder carcinoma. Basic and Applied Pathology 2012; 5(1): 1 doi: 10.1111/j.1755-9294.2012.01123.x
|
| 20 |
Lei Zhang, Martin H. Bluth, Amarpreet Bhalla. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract. Clinics in Laboratory Medicine 2018; 38(2): 367 doi: 10.1016/j.cll.2018.03.003
|
| 21 |
Manishankar Kumar, Arun Kumar, Abhinav Srivastav, Ashok Ghosh, Dhruv Kumar. Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2025; 830: 111896 doi: 10.1016/j.mrfmmm.2024.111896
|
| 22 |
Jian-Chun Cai, Di Liu, Kai-Hua Liu, Hai-Ping Zhang, Shan Zhong, Ning-Sao Xia. Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence. World Journal of Gastroenterology 2008; 14(25): 4070-4076 doi: 10.3748/wjg.14.4070
|
| 23 |
Takeaki Ikeda, Yoshifuku Nakayama, Yoshihiro Hamada, Morishige Takeshita, Hiroshi Iwasaki, Kensei Maeshiro, Yuichi Yamashita, Masahide Kuroki, Seiyo Ikeda. FU-MK-1 Expression in Human Gallbladder Carcinoma. American Journal of Clinical Pathology 2009; 132(1): 111 doi: 10.1309/AJCP5HPHG6NGBWZO
|
| 24 |
|
| 25 |
Pamela L. Kunz, Amirkaveh Mojtahed, George A. Fisher, James M. Ford, Daniel T. Chang, Raymond R. Balise, Charles D. Bangs, Athena M. Cherry, Reetesh K. Pai. HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population. Applied Immunohistochemistry & Molecular Morphology 2012; 20(1): 13 doi: 10.1097/PAI.0b013e31821c821c
|
| 26 |
Andrew S. Williams, Weei-Yuarn Huang. The analysis of microsatellite instability in extracolonic gastrointestinal malignancy. Pathology 2013; 45(6): 540 doi: 10.1097/PAT.0b013e3283653307
|
| 27 |
Carolina Bizama, Patricia García, Jaime A. Espinoza, Helga Weber, Pamela Leal, Bruno Nervi, Juan Carlos Roa. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy. Cancer Treatment Reviews 2015; 41(3): 222 doi: 10.1016/j.ctrv.2015.01.003
|
| 28 |
Yasuhisa Ando, Kensuke Kumamoto, Hiroyuki Matsukawa, Ryou Ishikawa, Hironobu Suto, Minoru Oshima, Hideki Kamada, Asahiro Morishita, Hideki Kobara, Toru Matsunaga, Reiji Haba, Tsutomu Masaki, Yasuyuki Suzuki, Keiichi Okano. Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital‑based population. Oncology Letters 2021; 23(1) doi: 10.3892/ol.2021.13122
|
| 29 |
Hiroshi Yoshida, Kazuaki Shimada, Nobuyoshi Hiraoka. Infrequent mismatch repair protein loss in gallbladder cancer patients in Japan. Virchows Archiv 2017; 470(1): 109 doi: 10.1007/s00428-016-2043-5
|
| 30 |
Genetic Changes of P53 and Kras in Gallbladder Carcinoma in Kumaon Region of Uttarakhand. Journal of Gastrointestinal Cancer 2020; 51(2): 552 doi: 10.1007/s12029-019-00283-0
|
| 31 |
Whayoung Lee, Vishal S. Chandan. Gallbladder carcinomas: review and updates on morphology, immunohistochemistry, and staging. Human Pathology 2023; 132: 149 doi: 10.1016/j.humpath.2022.06.013
|
| 32 |
Andrea P. Moy, Mohammad Shahid, Cristina R. Ferrone, Darrell R. Borger, Andrew X. Zhu, David Ting, Vikram Deshpande. Microsatellite instability in gallbladder carcinoma. Virchows Archiv 2015; 466(4): 393 doi: 10.1007/s00428-015-1720-0
|
| 33 |
Kizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, Kazuaki Takabe, Toshifumi Wakai. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017; 8(67): 112103 doi: 10.18632/oncotarget.22783
|
| 34 |
Michael Weindel, Muhammad Zulfiqar, Amarpreet Bhalla, Vinod B. Shidham. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gall Bladder, and Extrahepatic Biliary Tract. Clinics in Laboratory Medicine 2013; 33(4): 875 doi: 10.1016/j.cll.2013.08.002
|
| 35 |
Nabanita Roy, Mrinmoy Kshattry, Susmita Mandal, Mohit Kumar Jolly, Dhruba Kumar Bhattacharyya, Pankaj Barah. An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis. Journal of Clinical Medicine 2021; 10(16): 3520 doi: 10.3390/jcm10163520
|
| 36 |
Yoshihiro Isomura, Yutaka Yamaji, Miki Ohta, Motoko Seto, Yoshinari Asaoka, Yasuo Tanaka, Takashi Sasaki, Yousuke Nakai, Naoki Sasahira, Hiroyuki Isayama, Minoru Tada, Haruhiko Yoshida, Takao Kawabe, Masao Omata, Kazuhiko Koike. A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer. Journal of Gastroenterology 2010; 45(10): 1045 doi: 10.1007/s00535-010-0246-0
|
| 37 |
Vívian D’Afonseca, Ariel D Arencibia, Alex Echeverría-Vega, Leslie Cerpa, Juan P Cayún, Nelson M Varela, Marcela Salazar, Luis A Quiñones. Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach. Cancer Informatics 2020; 19 doi: 10.1177/1176935120922154
|
| 38 |
Cristina Sábato, Luciana Bastos-Rodrigues, Debora Chaves Moraes, Eitan Friedman, Luiz De Marco, Vivian Resende. Genetic Analysis of Brazilian Patients with Gallbladder Cancer. Pathology & Oncology Research 2019; 25(2): 811 doi: 10.1007/s12253-018-0407-7
|
| 39 |
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7
|
| 40 |
Dmitry Ratner, Jochen K. Lennerz. Implementing Keytruda/Pembrolizumab Testing in Clinical Practice. The Oncologist 2018; 23(6): 647 doi: 10.1634/theoncologist.2017-0591
|
| 41 |
Sanjeev K. Maurya, Mallika Tewari, Raghvendra R. Mishra, Hari S. Shukla. Genetic abberations in gallbladder cancer. Surgical Oncology 2012; 21(1): 37 doi: 10.1016/j.suronc.2010.09.003
|
| 42 |
|